These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
560 related articles for article (PubMed ID: 31983550)
1. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review]. Prevel R; Colin G; Calès V; Renault PA; Mazieres J Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550 [TBL] [Abstract][Full Text] [Related]
2. Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report. Monge C; Maeng H; Brofferio A; Apolo AB; Sathya B; Arai AE; Gulley JL; Bilusic M J Immunother Cancer; 2018 Dec; 6(1):150. PubMed ID: 30563577 [TBL] [Abstract][Full Text] [Related]
3. Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literature. Messer A; Drozd B; Glitza IC; Lu H; Patel AB Dermatol Online J; 2020 Aug; 26(8):. PubMed ID: 32941716 [TBL] [Abstract][Full Text] [Related]
5. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma. Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673 [TBL] [Abstract][Full Text] [Related]
6. [Dermatomyositis with squamous cell carcinoma of the lungs secondary to nivolumab treatment: a case report]. Miyashita K; Kajikawa H; Utsunomiya T; Hosaka M; Naito Y; Tomimoto H Rinsho Shinkeigaku; 2020 Nov; 60(11):768-772. PubMed ID: 33115992 [TBL] [Abstract][Full Text] [Related]
7. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring. Katsume Y; Isawa T; Toi Y; Fukuda R; Kondo Y; Sugawara S; Ootomo T Intern Med; 2018 Nov; 57(21):3157-3162. PubMed ID: 29877257 [TBL] [Abstract][Full Text] [Related]
8. Acute fatal myocarditis after a single dose of anti-PD-1 immunotherapy, autopsy findings: a case report. Hardy T; Yin M; Chavez JA; Ivanov I; Chen W; Nadasdy T; Brodsky SV Cardiovasc Pathol; 2020; 46():107202. PubMed ID: 32062109 [TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature. Saad R; Ghaddar A; Zeenny RM J Med Case Rep; 2024 Feb; 18(1):107. PubMed ID: 38383436 [TBL] [Abstract][Full Text] [Related]
12. Nivolumab-induced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer. Tan JL; Mugwagwa AN; Cieslik L; Joshi R BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31300602 [TBL] [Abstract][Full Text] [Related]
13. Case Report: Glucocorticoid Effect Observation in a Ureteral Urothelial Cancer Patient With ICI-Associated Myocarditis and Multiple Organ Injuries. Hu X; Wei Y; Shuai X Front Immunol; 2021; 12():799077. PubMed ID: 34975911 [TBL] [Abstract][Full Text] [Related]
14. Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report. Delombaerde D; Vervloet D; Berwouts D; Beckers R; Prenen H; Peeters M; Gremonprez F; Croes L; Vulsteke C J Med Case Rep; 2022 Jul; 16(1):275. PubMed ID: 35831829 [TBL] [Abstract][Full Text] [Related]
15. [New AMM: Nivolumab for advanced oesophageal squamous cell carcinomia after first line of chemotherapy]. Reich M; Coutzac C Bull Cancer; 2021 Mar; 108(3):228-229. PubMed ID: 33531154 [No Abstract] [Full Text] [Related]
17. Nivolumab-associated myositis myocarditis and myasthenia and anti-striated muscle antibodies. Fazal M; Prentice DA; Kho LK; Fysh E Intern Med J; 2020 Aug; 50(8):1003-1006. PubMed ID: 33306231 [TBL] [Abstract][Full Text] [Related]
18. Fatal myocarditis and rhabdomyolysis induced by nivolumab during the treatment of type B3 thymoma. Chen Q; Huang DS; Zhang LW; Li YQ; Wang HW; Liu HB Clin Toxicol (Phila); 2018 Jul; 56(7):667-671. PubMed ID: 29126352 [TBL] [Abstract][Full Text] [Related]
19. Asymptomatic Myocarditis with Mild Cardiac Marker Elevation Following Nivolumab-Induced Myositis. Shindo A; Yamasaki M; Uchino K; Yamasaki M Int Heart J; 2022; 63(1):180-183. PubMed ID: 35095069 [TBL] [Abstract][Full Text] [Related]
20. A closer look at immune-mediated myocarditis in the era of combined checkpoint blockade and targeted therapies. Guo CW; Alexander M; Dib Y; Lau PKH; Weppler AM; Au-Yeung G; Lee B; Khoo C; Mooney D; Joshi SB; Creati L; Sandhu S Eur J Cancer; 2020 Jan; 124():15-24. PubMed ID: 31707280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]